Dr. Paul Greengard's pioneering work in delineating how neurons communicate with one another in the brain earned him the 2000 Nobel Prize in Medicine or Physiology.
IND - The Institute for Neurodegenerative Disorders
The MSPRF sponsored research at the
IND is conducted under the direction of
Yale Professors Dr. Ken Marek and Dr. John Seibyl. This lab is
developing novel tools for early detection and monitoring of
Parkinson’s disease by studying physiologic, biochemical and
neuroimaging biomarkers for non-dominergic manifestations of
Parkinsonism.
The IND has been active in the
expansion of Amadeus (American and European Union SPECT Imaging
Consortium) to continue the application of rigorous, standardized
quantitative neuroimaging technology in multi-center trials to
improve diagnosis and evaluate treatments for Parkinson disease and
related disorders. They have initiated a multi-site study to develop
smell testing and brain imaging as a potential tool for early
diagnosis of Parkinson disease.
The IND will continue its research
and development of new ligands/biomarkers for neurodegenerative
disorders for Parkinson disease, and other neurological disorders.